Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndrome.

[1]  S. Homer-Vanniasinkam,et al.  Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. , 2008, Atherosclerosis.

[2]  Renu Virmani,et al.  Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.

[3]  E. Chaikof,et al.  Pathogen-Sensing Plasmacytoid Dendritic Cells Stimulate Cytotoxic T-Cell Function in the Atherosclerotic Plaque Through Interferon-&agr; , 2006, Circulation.

[4]  M. Böhm,et al.  Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome. , 2006, European heart journal.

[5]  J. Stone,et al.  T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α , 2006, Nature Immunology.

[6]  Kayoko Sato,et al.  T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome , 2006, Circulation research.

[7]  M. Goldstein,et al.  Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin , 2006, The Journal of experimental medicine.

[8]  R. Frye,et al.  TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque , 2006, The Journal of experimental medicine.

[9]  C. Baldari,et al.  Simvastatin inhibits T‐cell activation by selectively impairing the function of Ras superfamily GTPases , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  M. Desnos,et al.  In Vivo Induction of Endothelial Apoptosis Leads to Vessel Thrombosis and Endothelial Denudation: A Clue to the Understanding of the Mechanisms of Thrombotic Plaque Erosion , 2004, Circulation.

[11]  Qingbo Xu,et al.  Heat-Shock Protein 60-Reactive CD4+CD28null T Cells in Patients With Acute Coronary Syndromes , 2004, Circulation.

[12]  T. Toyo-Oka,et al.  Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development , 2003, Circulation research.

[13]  D. Cantrell.  GTPases and T cell activation , 2003, Immunological reviews.

[14]  B. Binder,et al.  Simvastatin Reduces the Expression of Adhesion Molecules in Circulating Monocytes From Hypercholesterolemic Patients , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[15]  S. Youssef,et al.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease , 2002, Nature.

[16]  R. Frye,et al.  T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes , 2002, Circulation.

[17]  R. Virmani,et al.  The thin-cap fibroatheroma: a type of vulnerable plaque: The major precursor lesion to acute coronary syndromes , 2001, Current opinion in cardiology.

[18]  F. Mach,et al.  Statins as a newly recognized type of immunomodulator , 2000, Nature Medicine.

[19]  M. Deckert,et al.  Vav modulation of the Ras / MEK / ERK signaling pathway plays a role in NFAT activation and CD69 up‐regulation , 2000, European journal of immunology.

[20]  K. Okumura,et al.  Type I Interferons (IFNs) Regulate Tumor Necrosis Factor–related Apoptosis-inducing Ligand (TRAIL) Expression on Human T Cells: A Novel Mechanism for the Antitumor Effects of  Type I IFNs , 1999, The Journal of experimental medicine.

[21]  J. Tschopp,et al.  TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. , 1997, Immunity.

[22]  R J Hohl,et al.  Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras. , 1996, Blood.

[23]  G. Hansson,et al.  Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. , 1996, The American journal of pathology.

[24]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[25]  S. Young,et al.  Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[28]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.